(Updated - January 24, 2022 6:00 AM EST)

BofA Securities analyst Lyanne Harrison upgraded ResMed (NYSE: RMD) from Underperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE